Virax Biolabs Group Limited Annual Return on Equity ROE, Trends, Fundamental Ratios - CSIMarket
CSIMarket Company Name, Ticker, Customers, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Virax Biolabs Group Limited  (NASDAQ: VRAX)

VRAX's ROE over the last five Years

Return on Equity, Annual Results, Trends, Rankings, Statistics


Return On Equity (Mar 31 2025)
2025		 (Mar 31 2024)
2024		 (Mar 31 2023)
2023		 (Mar 31 2021)
2022
Y / Y Equity Change 6.29 % -42.29 % - - -
Y / Y Net Income Change - - - - -
Return On Equity - - - - -

VRAX all Ratios >> Back to VRAX Management Effectiveness >> See Quarterly VRAX Return On Equity

You need to upgrade your Flash Player


Financial Statements
Virax Biolabs Group Limited's Equity $ 5 Millions Annual VRAX's Balance sheet
Virax Biolabs Group Limited's Annual Income $ -6 Millions Annual VRAX's Income Statement
Where are VRAX's Income coming from? Visit VRAX's Income by Segment





Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.